Overview

Positron Emission Tomography Imaging of Brain Amyloid in Normal Pressure Hydrocephalus

Status:
Terminated
Trial end date:
2011-04-01
Target enrollment:
Participant gender:
Summary
To determine the level of association between the quantitative estimates of brain uptake of [18F]flutemetamol and the quantitative immunohistochemical and histochemistry estimates of amyloid levels in frontal lobe biopsy samples obtained from subjects during shunt placement for NPH.
Phase:
Phase 3
Details
Lead Sponsor:
GE Healthcare
Collaborator:
i3 Statprobe
Treatments:
Flutemetamol